Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Desflurane for Cognitive Recovery in Down Syndrome
NCT02971254Phase 2Completed
- Sponsor
- Asklepieion Voulas General Hospital
- Start
- Dec 2016
- Primary completion
- Jan 2019
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Sevoflurane group with Desflurane group (2 arms). Primary endpoint: Change in Cognitive Functions at 4 hours. Started Dec 2016; status: completed.
02
Drugs
sevofluranedesflurane
Beyond the preview
Go deeper on NCT02971254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02971254.